Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases

被引：0
|
作者：
Joshua Kuruvilla
Andrew Octavian Sasmita
Anna Pick Kiong Ling
机构：
[1] International Medical University,Division of Applied Biomedical Sciences and Biotechnology, School of Health Sciences
来源：
Neurological Sciences | 2018年 / 39卷
关键词：
CRISPR/Cas9; Demyelination; Gene editing; Molecular neuroscience; Neurodegeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1827 / 1835
页数：8
相关论文
共 50 条
  • [21] CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
    Syding, Linn Amanda
    Nickl, Petr
    Kasparek, Petr
    Sedlacek, Radislav
    CELLS, 2020, 9 (04)
  • [22] CRISPR/Cas9 Essential Gene Editing in Drosophila
    Osadchiy, I. S.
    Kamalyan, S. O.
    Tumashova, K. Y.
    Georgiev, P. G.
    Maksimenko, O. G.
    ACTA NATURAE, 2023, 15 (02): : 70 - 74
  • [23] Optical Control of CRISPR/Cas9 Gene Editing
    Hemphill, James
    Borchardt, Erin K.
    Brown, Kalyn
    Asokan, Aravind
    Deiters, Alexander
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (17) : 5642 - 5645
  • [24] Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo
    Jiabin Zhang
    Jung-Hwan Lee
    Ju Jiao
    Du Cheng
    Li Liu
    Hae-Won Kim
    Yu Tao
    Mingqiang Li
    Signal Transduction and Targeted Therapy, 6
  • [25] GENE EDITING IN CHONDROCYTES USING CRISPR/CAS9
    Gibson, G.
    Yang, M.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S2 - S3
  • [26] Spatiotemporal control of CRISPR/Cas9 gene editing
    Zhuo, Chenya
    Zhang, Jiabin
    Lee, Jung-Hwan
    Jiao, Ju
    Cheng, Du
    Liu, Li
    Kim, Hae-Won
    Tao, Yu
    Li, Mingqiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [27] CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
    Yang, Weili
    Tu, Zhuchi
    Sun, Qiang
    Li, Xiao-Jiang
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [28] A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases
    Roshanravan, Neda
    Tutunchi, Helda
    Najafipour, Farzad
    Dastouri, Mohammadreza
    Ghaffari, Samad
    Jebeli, Alireza
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2022, 14 (02) : 77 - 83
  • [29] Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
    LaFountaine, Justin S.
    Fathe, Kristin
    Smyth, Hugh D. C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (01) : 180 - 194
  • [30] CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
    Mohammadzadeh, Iraj
    Qujeq, Durdi
    Yousefi, Tooba
    Ferns, Gordon A.
    Maniati, Mahmood
    Vaghari-Tabari, Mostafa
    IUBMB LIFE, 2020, 72 (08) : 1603 - 1621
12345